110 related articles for article (PubMed ID: 7919565)
61. Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C.
Gupta S; Basti S
Am J Ophthalmol; 1992 Oct; 114(4):503-4. PubMed ID: 1415465
[No Abstract] [Full Text] [Related]
62. A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma.
Longstaff S; Sigurdsson H; O'Keeffe M; Ogston S; Preece P
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1805-8. PubMed ID: 2632262
[TBL] [Abstract][Full Text] [Related]
63. Ocular and cutaneous effects of chronic phenothiazine therapy.
Bond WS; Yee GC
Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438
[No Abstract] [Full Text] [Related]
64. [Ophthalmologic side effects of drugs].
Karjalainen K
Duodecim; 1986; 102(18):1335-40. PubMed ID: 3769829
[No Abstract] [Full Text] [Related]
65. [Hemodilution in ocular circulation disorders].
Wiederholt M
Verh Dtsch Ges Inn Med; 1981; 87():1354-7. PubMed ID: 7331427
[No Abstract] [Full Text] [Related]
66. MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity.
Duncan KE; Chang LY; Patronas M
Eye (Lond); 2015 Aug; 29(8):1003-12. PubMed ID: 26043707
[TBL] [Abstract][Full Text] [Related]
67. Retinopathy associated with low-dose tamoxifen.
Chern S; Danis RP
Am J Ophthalmol; 1993 Sep; 116(3):372-3. PubMed ID: 8357064
[No Abstract] [Full Text] [Related]
68. Adverse ocular reactions to drugs.
Spiteri MA; James DG
Postgrad Med J; 1983 Jun; 59(692):343-9. PubMed ID: 6356101
[TBL] [Abstract][Full Text] [Related]
69. Ocular side effects of cancer chemotherapy.
Vizel M; Oster MW
Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524
[TBL] [Abstract][Full Text] [Related]
70. Assessment of visual function for patients on tamoxifen.
Duchesne GM
Clin Oncol (R Coll Radiol); 1993; 5(2):128. PubMed ID: 8481363
[No Abstract] [Full Text] [Related]
71. Interim report: National Registry of possible Drug-induced Ocular Side Effects.
Fraunfelder FT
Ophthalmology; 1980 Feb; 87(2):87-90. PubMed ID: 7383547
[No Abstract] [Full Text] [Related]
72. Ethambutol-induced ocular toxicity.
Tripathi SK
J Indian Med Assoc; 1988 Apr; 86(4):111-2. PubMed ID: 3171200
[No Abstract] [Full Text] [Related]
73. IDU ocular toxicity.
Angra SK
Indian J Ophthalmol; 1977 Jul; 25(2):38-41. PubMed ID: 615149
[No Abstract] [Full Text] [Related]
74. Severe Tamoxifen Retinopathy.
Kumari S; Virani B; Chawla R
Ophthalmol Retina; 2023 Dec; 7(12):1130. PubMed ID: 37865909
[No Abstract] [Full Text] [Related]
75. Chlorpromazine ocular toxicity.
Johnson AW
N C Med J; 1967 Nov; 28(11):474-6. PubMed ID: 5235902
[No Abstract] [Full Text] [Related]
76. A case of tamoxifen retinopathy associated with intermediate uveitis.
Ninet L; Mérité PY; Meyer F; Coupier L; Kaci A; Guigou S
J Fr Ophtalmol; 2021 Nov; 44(9):e533-e539. PubMed ID: 34244002
[No Abstract] [Full Text] [Related]
77. [Ocular complictions caused by drugs].
Babel J
Rev Med Suisse Romande; 1970 Nov; 90(11):835-44. PubMed ID: 5509263
[No Abstract] [Full Text] [Related]
78. Iatrogenic ocular diseases.
Sivayoham IS
Ceylon Med J; 1967 Sep; 12(3):163-7. PubMed ID: 5588668
[No Abstract] [Full Text] [Related]
79. [Ocular disorders due to tetramethyl-butane-diamine].
Smagghe G
Arch Mal Prof; 1967; 28(4):457-9. PubMed ID: 5623190
[No Abstract] [Full Text] [Related]
80. Tamoxifen-induced ocular toxicity.
Mihm LM; Barton TL
Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
